Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Irwin

Showing results (61-70 of 100) with videos related to

Pageof 10
Sort By:
Annals of Neurology|April 12, 2019
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementiaThomas F Tropea, Jordan Mak, Michael H Guo, et al.
Journal of Neuropathology and Experimental Neurology|October 21, 2022
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across TauopathiesDavid G Coughlin, Annie Hiniker, Claire Peterson, et al.
British Journal of Haematology|August 5, 2008
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myelomaRuben Niesvizky, Paul G Richardson, S Vincent Rajkumar, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 2018
Vascular Adaptation of the Right Ventricle in Experimental Pulmonary HypertensionBrian B Graham, Rahul Kumar, Claudia Mickael, et al.
Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.
High Altitude Medicine & Biology|December 19, 2015
Methazolamide Plus Aminophylline Abrogates Hypoxia-Mediated Endurance Exercise ImpairmentRebecca L Scalzo, Scott E Binns, Anna L Klochak, et al.
Neurobiology of Aging|April 26, 2021
CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementiaEmma L van der Ende, Estrella Morenas-Rodriguez, Corey McMillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trialPaul G Richardson, Jeff Wolf, Andrzej Jakubowiak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2024
Classical dendritic cells contribute to hypoxia-induced pulmonary hypertensionClaudia Mickael, Linda A Sanders, Michael H Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.
Pageof 10

Showing results (61-70 of 100) with videos related to

Sort By:
Pageof 10
Annals of Neurology|April 12, 2019
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementiaThomas F Tropea, Jordan Mak, Michael H Guo, et al.
Journal of Neuropathology and Experimental Neurology|October 21, 2022
Digital Histological Study of Neocortical Grey and White Matter Tau Burden Across TauopathiesDavid G Coughlin, Annie Hiniker, Claire Peterson, et al.
British Journal of Haematology|August 5, 2008
The relationship between quality of response and clinical benefit for patients treated on the bortezomib arm of the international, randomized, phase 3 APEX trial in relapsed multiple myelomaRuben Niesvizky, Paul G Richardson, S Vincent Rajkumar, et al.
American Journal of Respiratory Cell and Molecular Biology|June 1, 2018
Vascular Adaptation of the Right Ventricle in Experimental Pulmonary HypertensionBrian B Graham, Rahul Kumar, Claudia Mickael, et al.
Cancer|October 6, 2005
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myelomaJames R Berenson, Sundar Jagannath, Bart Barlogie, et al.
High Altitude Medicine & Biology|December 19, 2015
Methazolamide Plus Aminophylline Abrogates Hypoxia-Mediated Endurance Exercise ImpairmentRebecca L Scalzo, Scott E Binns, Anna L Klochak, et al.
Neurobiology of Aging|April 26, 2021
CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementiaEmma L van der Ende, Estrella Morenas-Rodriguez, Corey McMillan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Perifosine plus bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma previously treated with bortezomib: results of a multicenter phase I/II trialPaul G Richardson, Jeff Wolf, Andrzej Jakubowiak, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 30, 2024
Classical dendritic cells contribute to hypoxia-induced pulmonary hypertensionClaudia Mickael, Linda A Sanders, Michael H Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.
Pageof 10